On June 28, 2022, Henan Huamu Biotechnology Co., Ltd. successfully passed the acceptance of the "Veterinary Drug Good Manufacturing Practice Inspection and Acceptance Assessment Standards (2020 Revision)" (hereinafter referred to as the new version of Veterinary Drug GMP) with high standards.

Veterinary drug GMP is the basic requirements and guidelines for veterinary drug production management and quality control. It is a statutory technical specification commonly used by countries around the world to supervise and manage the entire process of veterinary drug production. Veterinary drug production is a very complex process involving many links and management. Negligence in any link may lead to product quality problems. In order to strengthen the quality management of veterinary drug production, in 2002, the former Ministry of Agriculture promulgated and implemented the Veterinary Drug GMP. Through the implementation of veterinary drug GMP, veterinary drug production behaviors are comprehensively standardized from personnel, factories, equipment, materials, documents, production processes, product sales, self-inspections, etc., to ensure the quality and safety of veterinary drug products, and to promote the healthy development of the veterinary drug industry and protect animals. Product quality and safety play an important role. On May 6, 2020, the "Good Manufacturing Practice for Veterinary Drugs (Revised in 2020)" (Ministry of Agriculture and Rural Affairs Order [2020] No. 3) was released and will be effective from June 1, 2020 (acceptance will be postponed for two years). This marks that my country’s veterinary drug industry has ushered in a new era of standards.

On June 28, 2022, a veterinary drug GMP acceptance expert group sent by the Ministry of Agriculture and Rural Affairs, accompanied by city and county leaders, visited Henan Huamu Biotechnology Co., Ltd. to conduct on-site assessment and acceptance.

After listening to the report on the implementation of the company's new version of veterinary drug GMP, the expert group conducted on-site inspections in laboratories, production workshops, warehouses, etc., and then carefully reviewed the company's new version of veterinary drug GMP management documents, files, records, etc., and reviewed all aspects of the company's new version of veterinary drug GMP. Department heads and key position operators conducted on-site questions and assessments.

After strict inspection and comprehensive evaluation by the expert group, Henan Huamu Biotechnology Co., Ltd. meets the requirements of the new version of Veterinary Drug Production Quality Management Standards. Our company’s traditional Chinese medicine extraction, granules, oral liquids, tablets, powders, and powders , premixes, insecticides, disinfectants and other nine production lines passed the new version of GMP acceptance at one time with high standards.

Passing the acceptance of the new version of veterinary drug GMP is just a small test on the development path for Huamu Biological. In the future, we will take this as an opportunity to continue to innovate, continue to increase research and development efforts, and continue to improve all personnel. business capabilities and levels, implement the new version of veterinary drug GMP regulations and requirements more deeply, pay attention to every detail of the product production process, make the entire production process streamlined, intelligent, and traceable, strictly control product quality, and provide our customers with more Safe and efficient products help the sustainable and healthy development of my country's livestock industry.

There will be times to ride the wind and waves, and sail directly to the sea. In the future development path, Henan Huamu Biotechnology Co., Ltd. will adhere to the service concept of creating value for customers wholeheartedly and escorting the healthy development of the animal husbandry industry. It will not forget its original intention and keep its mission in mind. , and make our greatest contribution to the great rejuvenation of the Chinese nation.